CARsgen's Satri-cel NDA Accepted by China's NMPA for Gastric Adenocarcinoma
CompanyDrug

CARsgen’s Satri-cel NDA Accepted by China’s NMPA for Gastric Adenocarcinoma

Lepu Biotech Gains EMA Approval for MRG003 HNSCC Clinical Trial
CompanyDrug

Lepu Biopharma Gains EMA Approval for MRG003 HNSCC Clinical Trial

RemeGen Inks Global Licensing Pact With Vor Bio for Telitacicept
CompanyDeals

RemeGen Inks Global Licensing Pact With Vor Biopharma for Telitacicept

Angel Pharma Gains NMPA Approval for Soquelitinib in Atopic Dermatitis Trial
CompanyDrug

Angel Pharma Gains NMPA Approval for Soquelitinib in Atopic Dermatitis Trial

Biogen's Phase I Results Highlight Salanersen's Potential in Spinal Muscular Atrophy
CompanyDrug

Biogen’s Phase I Results Highlight Salanersen’s Potential in Spinal Muscular Atrophy

Kymera and Sanofi Advance IRAK4 Program With Selection of KT-485 for Clinical Development
CompanyDeals

Kymera and Sanofi Advance IRAK4 Program With Selection of KT-485 for Clinical Development

LG Chem's Cross-Linked Sodium Hyaluronate Gel Gains NMPA Approval for Midface Use
CompanyDrug

LG Chem’s Cross-Linked Sodium Hyaluronate Gel Gains NMPA Approval for Midface Use

Porton Pharma Partners With EVA Pharma to Boost CAR-T Cell Therapy in MENA
CompanyDeals

Porton Advanced Partners With EVA Pharma to Boost CAR-T Cell Therapy in MENA

Eli Lilly's Amyvid Sees FDA-Approved Label Update for Alzheimer's Diagnosis
CompanyDrug

Eli Lilly’s Amyvid Sees FDA-Approved Label Update for Alzheimer’s Diagnosis

Gilead Signs Licensing Pact With Kymera Therapeutics for CDK2-Targeted MGD
CompanyDeals

Gilead Signs Licensing Pact With Kymera Therapeutics for CDK2-Targeted MGD

SineuGene's ALS Gene Therapy SNUG01 Granted FDA Orphan Drug Designation
CompanyDrug

SineuGene’s ALS Gene Therapy SNUG01 Granted FDA Orphan Drug Designation

Acotec Scientific Wins NMPA Approval for Armoni-HP Balloon Catheter
CompanyDrug

Acotec Scientific Wins NMPA Approval for Armoni-HP Balloon Catheter